Congress Asset Management Co. decreased its stake in Oracle Co. (NYSE:ORCL - Free Report) by 1.8% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 108,145 shares of the enterprise software provider's stock after selling 1,950 shares during the quarter. Congress Asset Management Co.'s holdings in Oracle were worth $15,120,000 at the end of the most recent quarter.
A number of other institutional investors also recently modified their holdings of the stock. Impact Capital Partners LLC grew its stake in Oracle by 5.2% in the first quarter. Impact Capital Partners LLC now owns 25,652 shares of the enterprise software provider's stock valued at $3,586,000 after purchasing an additional 1,273 shares in the last quarter. Horizon Wealth Management LLC lifted its holdings in shares of Oracle by 8.1% during the 1st quarter. Horizon Wealth Management LLC now owns 2,595 shares of the enterprise software provider's stock valued at $363,000 after buying an additional 194 shares during the last quarter. Prospect Financial Services LLC grew its stake in shares of Oracle by 119.1% in the 1st quarter. Prospect Financial Services LLC now owns 2,750 shares of the enterprise software provider's stock valued at $385,000 after buying an additional 1,495 shares in the last quarter. Procyon Advisors LLC raised its position in Oracle by 2.7% during the first quarter. Procyon Advisors LLC now owns 97,525 shares of the enterprise software provider's stock valued at $13,635,000 after acquiring an additional 2,521 shares in the last quarter. Finally, Intellectus Partners LLC lifted its stake in Oracle by 6.9% in the first quarter. Intellectus Partners LLC now owns 13,621 shares of the enterprise software provider's stock valued at $1,904,000 after acquiring an additional 878 shares during the last quarter. Institutional investors and hedge funds own 42.44% of the company's stock.
Insider Buying and Selling
In other Oracle news, Director Naomi O. Seligman sold 2,866 shares of the business's stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $149.53, for a total transaction of $428,552.98. Following the completion of the sale, the director now directly owns 31,764 shares of the company's stock, valued at approximately $4,749,670.92. The trade was a 8.28% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Leon E. Panetta sold 5,000 shares of the firm's stock in a transaction dated Friday, April 11th. The shares were sold at an average price of $129.77, for a total transaction of $648,850.00. Following the completion of the transaction, the director now directly owns 58,090 shares in the company, valued at $7,538,339.30. This trade represents a 7.93% decrease in their position. The disclosure for this sale can be found here. Insiders sold 27,366 shares of company stock worth $4,015,723 in the last quarter. Insiders own 42.20% of the company's stock.
Wall Street Analyst Weigh In
ORCL has been the topic of a number of recent research reports. Jefferies Financial Group raised their price target on shares of Oracle from $190.00 to $200.00 and gave the company a "buy" rating in a report on Monday. Monness Crespi & Hardt raised Oracle from a "sell" rating to a "neutral" rating in a research report on Monday, March 3rd. BMO Capital Markets upped their price target on Oracle from $175.00 to $200.00 and gave the stock a "market perform" rating in a research note on Monday. Piper Sandler restated a "neutral" rating and issued a $130.00 target price (down from $190.00) on shares of Oracle in a report on Wednesday, April 23rd. Finally, Guggenheim reiterated a "buy" rating and set a $220.00 price target on shares of Oracle in a report on Thursday. Thirteen research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $177.35.
Check Out Our Latest Research Report on ORCL
Oracle Price Performance
Shares of Oracle stock traded up $3.17 during midday trading on Monday, hitting $177.19. 9,659,888 shares of the company were exchanged, compared to its average volume of 9,510,942. The firm has a 50 day simple moving average of $147.20 and a 200-day simple moving average of $160.24. Oracle Co. has a 52 week low of $118.86 and a 52 week high of $198.31. The firm has a market cap of $495.60 billion, a P/E ratio of 43.32, a PEG ratio of 3.46 and a beta of 1.32. The company has a debt-to-equity ratio of 5.65, a current ratio of 0.81 and a quick ratio of 0.81.
Oracle (NYSE:ORCL - Get Free Report) last issued its earnings results on Monday, March 10th. The enterprise software provider reported $1.47 EPS for the quarter, missing the consensus estimate of $1.49 by ($0.02). Oracle had a net margin of 21.16% and a return on equity of 133.25%. The firm had revenue of $14.13 billion during the quarter, compared to analyst estimates of $14.40 billion. During the same quarter in the prior year, the firm posted $1.41 EPS. The firm's revenue for the quarter was up 6.4% on a year-over-year basis. Research analysts forecast that Oracle Co. will post 5 earnings per share for the current year.
Oracle Company Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Read More

Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.